News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
357,327 Results
Type
Article (14326)
Company Profile (128)
Press Release (342873)
Section
Business (112563)
Career Advice (450)
Deals (18593)
Drug Delivery (25)
Drug Development (31128)
Employer Resources (49)
FDA (8785)
Job Trends (7660)
News (172635)
Policy (12347)
Tag
Academia (1314)
Alliances (34547)
Alzheimer's disease (440)
Approvals (8762)
Artificial intelligence (115)
Bankruptcy (129)
Best Places to Work (6422)
Biotechnology (97)
Breast cancer (46)
Cancer (435)
Career advice (401)
Cell therapy (127)
Clinical research (23710)
Collaboration (247)
Compensation (42)
COVID-19 (1108)
C-suite (47)
Data (411)
Diagnostics (4699)
Earnings (37496)
Employer resources (42)
Events (49909)
Executive appointments (130)
FDA (9005)
Funding (186)
Gene editing (46)
Gene therapy (85)
GLP-1 (183)
Government (1222)
Healthcare (9805)
Infectious disease (1145)
Inflammatory bowel disease (48)
Interviews (49)
IPO (7908)
Job creations (1433)
Job search strategy (359)
Layoffs (108)
Legal (2506)
Lung cancer (63)
Manufacturing (87)
Medical device (11292)
Medtech (11297)
Mergers & acquisitions (10748)
Metabolic disorders (105)
Neuroscience (523)
NextGen Class of 2024 (3527)
Non-profit (1511)
Northern California (566)
Obesity (54)
Opinion (65)
Patents (61)
People (32110)
Phase I (8735)
Phase II (10731)
Phase III (6934)
Pipeline (104)
Postmarket research (501)
Preclinical (3963)
Press Release (66)
Radiopharmaceuticals (147)
Rare diseases (76)
Real estate (3346)
Regulatory (9030)
Research institute (1265)
Resumes & cover letters (67)
Southern California (565)
Startups (2499)
United States (5937)
Vaccines (233)
Date
Today (54)
Last 7 days (383)
Last 30 days (1423)
Last 365 days (19195)
2024 (16161)
2023 (22098)
2022 (30813)
2021 (32514)
2020 (30539)
2019 (25796)
2018 (19459)
2017 (18871)
2016 (17761)
2015 (20560)
2014 (15177)
2013 (12742)
2012 (13781)
2011 (14066)
2010 (12826)
Location
Africa (314)
Arizona (92)
Asia (23575)
Australia (4104)
California (1335)
Canada (618)
China (106)
Colorado (78)
Connecticut (66)
Europe (48042)
Florida (215)
Georgia (69)
Illinois (154)
Indiana (83)
Kansas (75)
Maryland (281)
Massachusetts (968)
Michigan (128)
Minnesota (160)
New Hampshire (56)
New Jersey (439)
New York (400)
North Carolina (366)
Northern California (566)
Ohio (64)
Pennsylvania (295)
South America (504)
Southern California (565)
Texas (208)
Utah (49)
Washington State (206)
357,327 Results for "axosim technologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
AxoSim Extends Leadership in Human Organoids for Neurological Drug Discovery with Acquisition of StemoniX microBrain™ Technology
AxoSim, Inc. announced completion of its acquisition of the microBrain™ associated assets of Vyant Bio’s StemoniX subsidiary.
October 24, 2023
·
5 min read
Deals
AxoSim Enters Into a Definitive Agreement to Acquire Vyant Bio’s StemoniX Assets
AxoSim, Inc., a leader in the development and application of human biomimetic platforms for neurological diseases, and Vyant Bio, Inc. (OTC: VYNT) (Vyant Bio) today announced that they have entered into a definitive agreement under which AxoSim will acquire the microBrain™-associated assets of Vyant Bio’s StemoniX subsidiary.
July 17, 2023
·
9 min read
BioMidwest
Silq Technologies Receives Innovative Technology Contract From Vizient for ClearTract® Foley Catheter
Silq Technologies announced its ClearTract® Foley Catheter has received an Innovative Technology contract from Vizient, Inc., the nation’s largest provider-driven healthcare performance improvement company.
June 13, 2024
·
3 min read
Business
Xironetic Appoints Jeff Potts to Chief Technology Officer
Xironetic, a provider of augmented reality surgical guidance technology, is announcing the appointment of Jeff Potts to Chief Technology Officer.
June 19, 2024
·
2 min read
Press Releases
180 Life Sciences Corp. Retains Senior Technology Consultant and Commences Gaming Technology Platform Integration
October 31, 2024
·
8 min read
Press Releases
Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on November 5th
November 4, 2024
·
2 min read
Business
Spineart Appoints Laurent Nodé-Langlois as Chief Technology Officer to Lead Enabling Technologies Business Unit
Spineart, a fast-growing company specialized in spine surgery innovation, is pleased to announce the appointment of Laurent Nodé-Langlois as Chief Technology Officer.
June 28, 2024
·
2 min read
Biotech Bay
AbTherx Opens Antibody Discovery Technologies Research Center
AbTherx, Inc., a biotechnology company with innovative technologies that enable and accelerate antibody discovery, announced the opening of its new antibody discovery technologies research center.
June 18, 2024
·
3 min read
BioMidwest
SINTX Technologies to Explore Strategic Opportunities
SINTX Technologies, Inc. announced that its Board of Directors has initiated a process to explore potential strategic options for the Company.
June 18, 2024
·
4 min read
Shineco Enters into a Letter of Intent with Meitong Technology to Address China’s Aging Population
Shineco Inc. announced that on June 18, 2024, it entered into an Investment Letter of Intent with Beijing Oriental Meitong Technology Co., Ltd. whereby Shineco intends to invest $20 million in Meitong Technology in exchange for 80% of Meitong Technology’s shares.
June 20, 2024
·
6 min read
1 of 35,733
Next
